Exicure Q1 FY26 net loss widens to $1.83 million; R&D expense drops 61% to $312,000

Exicure, Inc.

Exicure, Inc.

XCUR

0.00
  • Exicure posted a net loss of USD 1.83 million, swinging from net income of USD 3.01 million a year earlier.
  • Operating results turned to an operating loss of USD 1.64 million from operating income of USD 2.92 million in the prior-year quarter.
  • Research and development expense fell 61% to USD 312,000; general and administrative expense dropped 42% to USD 1.29 million.
  • Cash and cash equivalents totaled about USD 2.6 million as of March 31, 2026, with management flagging substantial doubt about going-concern status.
  • Plans include a USD 1 million milestone payment to GPCR in shares in Q2 2026 as GPCR USA advances a stem-cell mobilization study.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001698530-26-000057), on May 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.